Meanwhile, CDCA8 knockdown also inhibits cell proliferation and promotes cell differentiation in colorectal cancer, lung cancer, breast cancer, cutaneous melanoma, and human embryonic stem cells (61–65). Here, CDCA8 is linked to lung carcinoma.